Company Number: 14653893

Analysis Date: 2025-07-29 17:30 UTC

Financial Health Assessment for LIISBORN TECHNOLOGY LTD

---

1. Financial Health Score: B

Explanation:
LIISBORN TECHNOLOGY LTD is a newly incorporated private limited company classified as dormant, with stable net assets of £50,000 over three reported years. The company has no operational activity or financial transactions recorded, reflecting a "healthy but dormant" financial state. The score B reflects solid initial capitalization and compliance with filing requirements but also the absence of operating performance data, which limits a full financial vitality assessment.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Status	Active, Dormant	No trading activity; company is registered but currently inactive
Net Assets	£50,000	Stable shareholder equity; good initial capitalization
Share Capital	£50,000 (50,000 shares)	Fully paid share capital, showing sound financial base
Filing Status	Up to date	Accounts and confirmation statements filed on time; good compliance health
Directors	One active director	Stable governance structure, though some turnover noted
Industry Classification	Wholesale trade (non-specialised and electronics)	Indicates intended business sector, though no current trading
Dormant Status	Confirmed under Companies Act 2006, Section 480	No significant financial transactions recorded
Ownership	Single PSC with 75-100% control	Clear ownership and control, reducing governance complexity

---

3. Diagnosis:

• Healthy Capital Foundation: The company’s net assets and shareholders’ funds remain stable at £50,000, indicating a strong capital base with no erosion of equity. This acts like a "healthy pulse," showing the company is financially sound at a base level.
• Dormant Status (Symptom of Inactivity): The company has not engaged in any trading activity or financial transactions during the reported periods, which signals a "resting" state. While this avoids risks associated with operating losses, it also means there are no revenues or cash flows to analyze.
• Compliance and Governance: Timely filing of accounts and confirmation statements shows the company "breathes" properly in regulatory terms, avoiding penalties or legal complications. The presence of a single controlling shareholder with clear control is a "stable nervous system," ensuring decision-making clarity.
• Limited Operational Data: The absence of profit and loss statements or cash flow data means there are no "vital signs" from trading activities to evaluate performance, growth potential, or operational risks.
• Director Turnover: Some recent short-term appointments and resignations of directors could indicate minor "nervous irritations" within governance, but no significant distress signals as the company remains compliant and operationally dormant.

---

4. Recommendations:

• Activate Trading Operations: To move from dormancy to active business status, start generating revenues and expenses to provide a full financial health picture. This is akin to "starting exercise" to build muscle and stamina.
• Maintain Compliance Vigilance: Continue timely filings to preserve good standing and avoid penalties or enforcement actions. Good regulatory "hygiene" is essential.
• Strengthen Governance: Ensure director appointments are stable and suited to the company’s strategic objectives to avoid governance "arrhythmias."
• Prepare Financial Projections: Develop budgets and forecasts to monitor future cash flows and profitability once active trading resumes, providing early warning signs of financial distress or opportunity.
• Consider Capital Needs: Depending on business plans, assess whether the initial £50,000 capital is sufficient to sustain operations or if additional funding will be required.

---